Solving Visual Inspection Challenges in Difficult-to-Inspect Products

Pharmaceutical regulatory instructions are absolute: 100% visual inspection is mandatory for all parenteral products, regardless of content or container complexity. However, standard inspection systems are frequently pushed to their physical limits by opaque solutions, lyophilized cakes, and complex delivery systems. Transitioning from standard inspection methodologies to advanced Automated Visual Inspection (AVI) allows manufacturers to bridge the compliance gap, ensuring robust particulate control while satisfying stringent validation standards.

A Difficult-to-Inspect Parenteral (DIP) product is defined by specific physical characteristics of the product or primary packaging configuration that obstruct light transmission and hinder standard optical inspection.

Formulation Challenges

These include opaque, turbid, or heavily colored solutions; powders and lyophilized (freeze-dried) cakes; emulsions and suspensions; protein-based products; highly viscous solutions; and unstable, complex biotech drugs.

Product-Packaging Configurations

These include non-transparent plastic containers; dark or colored glass containers (such as amber ampoules); Blow-Fill-Seal (BFS) containers; flexible infusion bags; and secondary packaging assemblies like completed auto-injectors.

This complexity creates an industry-wide compliance challenge. According to a landmark Parenteral Drug Association (PDA) survey, the industry was found to be challenged regarding particulate control in DIP products. With regulatory scrutiny regarding particulate contamination steadily increasing, relying on standard inspection setups is no longer a viable operational strategy.

Regulatory bodies do not grant exemptions for product complexity. Inspection protocols must satisfy the following core requirements:

• USP <1> (Injections and Implanted Drug Products): Dictates that all products intended for parenteral administration must be visually inspected for the presence of particulate matter. Every container showing evidence of visible particulates must be rejected.
• USP <790> (Visible Particulates in Injections): Defines the framework for 100% inspection during manufacturing to demonstrate that a batch is "essentially free" of visible particulates. This is also applicable for difficult-to-inspect products, although with some exceptions.

Additional Regulatory Recommendations for DIP Products

Because non-destructive testing faces physical obstacles in DIP applications, authorities recommend a multi-layered inspection strategy:

1. Statistical AQL Sampling: A statistical visual inspection must be conducted post-100% inspection to assess batch quality against Acceptable Quality Limits (AQL) using a formal sampling plan.
2. Supplemental Destructive Testing: In accordance with USP <790>, where the container or product characteristics limit non-destructive visibility, 100% inspection must be supplemented by destructive testing (e.g., reconstituting dried powders or withdrawing liquid from dark amber containers) using a smaller, statistically valid sample size.
3. Reject and Trend Monitoring: Continuous tracking of true and false rejects must be maintained to support upstream process controls and monitor line performance.

The designation of a product as a DIP relates specifically to the system's capability to detect particles. The physical properties of the formulation (e.g., surface tension, viscosity, opacity) and the primary packaging (e.g., material density, color, stress resistance) significantly reduce the Probability of Detection (POD).

This physical packaging configuration shifts the nominal detection thresholds:

• Standard Products: The nominal detection limit for visible particles sits between 100μm  and 150μm .
• DIP Products: The nominal detection limit for particles shifts up to 300μm .

Note on Non-Particulate Defects: While particle detection limits are adapted to accommodate DIP properties, all other structural container-closure defects must still be detected with the identical probability required for standard, clear-liquid products.

During algorithm development, engineers are encouraged to challenge the AVI software with "grey zone" defects (defects with a  POD) to optimize discrimination performance. 

To replace manual human inspectors with an automated inspection solution, manufacturers must comply with explicit equivalency mandates:

• USP <1790>: "Where machine methods are used, the equipment must be validated to demonstrate equivalent or better performance when compared to manual inspection."
• EU GMP Annex 1 (Clause 8.32): "Where automated methods of inspection are used, the process should be validated to detect known defects (which may impact product quality or safety) and be equal to or better than manual inspection methods." 

Achieving compliance across small-batch lines and high-speed inline systems requires an inspection platform tailored to the specific optical properties of the product and container.

1. 100% Non-Destructive Inspection (Tuned to Product & Container)

• Custom camera and illumination geometries are developed for each unique DIP configuration to optimize image quality.
• Advanced algorithms differentiate true defects from product-inherent features (such as distinguishing moving foreign particles from harmless product bubbles).
• The configured setup ensures detection sensitivity that meets or exceeds manual compendial inspection standards.

2. Integrated AQL Acceptance Sampling

• Statistical sampling protocols are built directly into the automated inspection machine's mechanical workflow.
• Full batch data can be exported to generate audit-ready, GMP-compliant documentation and historical trend analysis.
• Defect classification software categorizes failures by exact location and optical station, isolating particulate contamination from structural container flaws.

3. Full Lifecycle Engineering Support

• Comprehensive lifecycle assistance guides projects from initial custom solution design and softwarerecipe development through installation and qualification.
• Preventive maintenance plans, flexible qualification packages, and personalized support programs ensure the system remains validated over its operational life.